Junxun Ma

机构：Chinese PLA General Hospital

发表论文 71 篇 · 总被引 1276 次 · h-index 22

代表论文

• The efficacy of immune checkpoint inhibitors in advanced EGFR-Mutated non-small cell lung cancer after resistance to EGFR-TKIs: Real-World evidence from a multicenter retrospective study (2022 · Frontiers in Immunology · 被引 23)
• Deciphering pathogenic cellular module at single-cell resolution in checkpoint inhibitor-related pneumonitis (2023 · Oncogene · 被引 21)
• Gut mycobiome as a potential non-invasive tool in early detection of lung adenocarcinoma: a cross-sectional study (2023 · BMC Medicine · 被引 20)
• Comparison of efficacy and safety between PD-1 inhibitors and PD-L1 inhibitors plus platinum-etoposide as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, real-world analysis (2023 · BMC Cancer · 被引 14)
• Efficacy and safety of pembrolizumab versus sintilimab treatment in patients with advanced squamous lung cancer: A real-world study in China (2023 · Frontiers in Oncology · 被引 10)
• STING facilitates the development of radiation-induced lung injury via regulating the PERK/eIF2α pathway (2024 · Translational Lung Cancer Research · 被引 9)